Skip to main navigation
Skip to search
Skip to main content
Prinses Máxima Centrum Home
Nederlands
English
Search content at Prinses Máxima Centrum
Home
Profiles
Research Groups
Equipment
Research output
Prizes
Activities
Press/Media
Respiratory syncytial virus bronchiolitis: Prevention and treatment
Tina E. Faber
, Jan L.L. Kimpen
,
Louis J. Bont
Research output
:
Contribution to journal
›
Review article
›
peer-review
9
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Respiratory syncytial virus bronchiolitis: Prevention and treatment'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Respiratory Syncytial Virus Infection
100%
Respiratory Syncytial Virus
100%
Respiratory Syncytial Virus Bronchiolitis
100%
Therapeutic Strategies
50%
Very Young children
50%
Most Common Cause
50%
Virus
50%
Children at Risk
50%
Specific Monoclonal Antibodies
50%
Futures Past
50%
Innovative Vaccines
50%
Preventive Strategies
50%
Past-present
50%
Immunological Diseases
50%
Airway Morbidity
50%
Causes of Hospitalization
50%
Severe Respiratory Syncytial Virus
50%
Acute Respiratory Illness
50%
Medicine and Dentistry
Human Respiratory Syncytial Virus
100%
Bronchiolitis
100%
Respiratory Syncytial Virus Infection
66%
Monoclonal Antibody
33%
Morbidity
33%
Respiratory Disease
33%
Immunopathology
33%
Diseases
33%
Virus
33%
Pharmacology, Toxicology and Pharmaceutical Science
Human Respiratory Syncytial Virus
100%
Bronchiolitis
100%
Respiratory Syncytial Virus Infection
66%
Monoclonal Antibody
33%
Respiratory Tract Disease
33%
Immunopathology
33%
Morbidity
33%
Diseases
33%
Virus
33%
Immunology and Microbiology
Human Respiratory Syncytial Virus
100%
Bronchiolitis
100%
Respiratory Syncytial Virus Infection
66%
Monoclonal Antibody
33%
Immunopathology
33%
Morbidity
33%
Airway
33%
Virus
33%